These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 9652307

  • 1. Inhibitory effects of lodoxamide on eosinophil activation.
    Capron M, Loiseau S, Papin JP, Robertson S, Capron A.
    Int Arch Allergy Immunol; 1998 Jun; 116(2):140-6. PubMed ID: 9652307
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effects of ketotifen on eotaxin-dependent activation of eosinophils: consequences for allergic eye diseases.
    Woerly G, Loiseau S, Loyens M, Schoch C, Capron M.
    Allergy; 2003 May; 58(5):397-406. PubMed ID: 12752326
    [Abstract] [Full Text] [Related]

  • 3. Eosinophils express a functional receptor for interferon alpha: inhibitory role of interferon alpha on the release of mediators.
    Aldebert D, Lamkhioued B, Desaint C, Gounni AS, Goldman M, Capron A, Prin L, Capron M.
    Blood; 1996 Mar 15; 87(6):2354-60. PubMed ID: 8630398
    [Abstract] [Full Text] [Related]

  • 4. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G, Decot V, Loiseau S, Loyens M, Chihara J, Ono N, Capron M.
    Clin Exp Allergy; 2004 Sep 15; 34(9):1379-87. PubMed ID: 15347370
    [Abstract] [Full Text] [Related]

  • 5. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis.
    Leonardi A, Borghesan F, Avarello A, Plebani M, Secchi AG.
    Br J Ophthalmol; 1997 Jan 15; 81(1):23-6. PubMed ID: 9135403
    [Abstract] [Full Text] [Related]

  • 6. Effects of ketotifen 0.025% and lodoxamide 0.1% on eosinophil infiltration into the guinea pig conjunctiva in a model of allergic conjunctivitis.
    Schoch C.
    J Ocul Pharmacol Ther; 2003 Apr 15; 19(2):153-9. PubMed ID: 12804060
    [Abstract] [Full Text] [Related]

  • 7. TNF alpha-induced activation of eosinophil oxidative metabolism and morphology--comparison with IL-5.
    Zeck-Kapp G, Czech W, Kapp A.
    Exp Dermatol; 1994 Aug 15; 3(4):176-88. PubMed ID: 8000707
    [Abstract] [Full Text] [Related]

  • 8. Eosinophil granule proteins activate human heart mast cells.
    Patella V, de Crescenzo G, Marinò I, Genovese A, Adt M, Gleich GJ, Marone G.
    J Immunol; 1996 Aug 01; 157(3):1219-25. PubMed ID: 8757629
    [Abstract] [Full Text] [Related]

  • 9. Granular proteins of eosinophils.
    Monteseirín J, Prados M, Bonilla I, Llamas E, Delgado J, Sánchez-Monteseirín H, Chaparro A, Conde J.
    Allergol Immunopathol (Madr); 1996 Aug 01; 24(5):219-25. PubMed ID: 8985478
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein.
    Winqvist I, Olofsson T, Olsson I.
    Immunology; 1984 Jan 01; 51(1):1-8. PubMed ID: 6317543
    [Abstract] [Full Text] [Related]

  • 12. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.
    Kita H, Abu-Ghazaleh RI, Sur S, Gleich GJ.
    J Immunol; 1995 May 01; 154(9):4749-58. PubMed ID: 7722326
    [Abstract] [Full Text] [Related]

  • 13. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens.
    Rosenberg HF, Domachowske JB.
    J Leukoc Biol; 2001 Nov 01; 70(5):691-8. PubMed ID: 11698487
    [Abstract] [Full Text] [Related]

  • 14. Partial purification and biological properties of an eosinophil-activating factor.
    Thorne KJ, Richardson BA, Veith MC, Tai PC, Spry CJ, Butterworth AE.
    Eur J Immunol; 1985 Nov 01; 15(11):1083-91. PubMed ID: 2998804
    [Abstract] [Full Text] [Related]

  • 15. Selectivity of mediators released by eosinophils.
    Capron M, Tomassini M, Torpier G, Kusnierz JP, MacDonald S, Capron A.
    Int Arch Allergy Appl Immunol; 1989 Nov 01; 88(1-2):54-8. PubMed ID: 2523359
    [Abstract] [Full Text] [Related]

  • 16. The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer.
    Trulson A, Nilsson S, Venge P.
    Br J Haematol; 1997 Aug 01; 98(2):312-4. PubMed ID: 9266926
    [Abstract] [Full Text] [Related]

  • 17. [The role of eosinophils in bronchial asthma].
    Pałczyński C, Górski P.
    Pol Arch Med Wewn; 1988 Jun 01; 79(6):332-7. PubMed ID: 3078201
    [No Abstract] [Full Text] [Related]

  • 18. The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF.
    Kapp A, Zeck-Kapp G, Czech W, Schöpf E.
    J Invest Dermatol; 1994 Jun 01; 102(6):906-14. PubMed ID: 7516398
    [Abstract] [Full Text] [Related]

  • 19. [Eosinophil-induced lung injury].
    Iwamoto I.
    Kokyu To Junkan; 1991 Jun 01; 39(6):514-21. PubMed ID: 1871435
    [No Abstract] [Full Text] [Related]

  • 20. Pitfalls in the quantitative estimation of the secretion of granule proteins by eosinophils.
    Bach MK, Brashler JR, Sanders ME, Bienkowski MJ.
    J Immunol Methods; 1991 Sep 13; 142(2):243-50. PubMed ID: 1919027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.